 |
市場調查報告書
商品編碼
1567141
熊去氧膽酸市場：按劑型、按提取方法、按應用、按分銷管道、按地區Ursodeoxycholic Acid Market, By Dosage Form, By Mode of Extraction, By Application, By Distribution Channel, By Geography |
||||||
預計 2024 年全球熊去氧膽酸市場規模為 5.901 億美元，預計 2031 年將達到 11.652 億美元，2024 年至 2031 年複合年成長率為 10.2%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 5.901 億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 10.20% | 2031年價值預測 | 11.652 億美元 |
熊去氧膽酸是肝臟產生的膽汁酸，有助於消化和吸收攝取的脂肪。它用於治療各種與肝臟相關的疾病，例如原發性膽汁性肝硬化（PBC）和膽結石。全球熊去氧膽酸市場的成長是由於肝臟疾病盛行率的上升以及人們對熊去氧膽酸治療益處的認知不斷提高而推動的。市場相關人員正在大力投資研發，以開發熊去氧膽酸的新配方和開拓形式，並擴大消費群。
市場動態：
全球熊去氧膽酸市場的成長是由於越來越多的老年人更容易受到肝損傷、新興市場醫療保健支出的增加以及擴大採用熊去氧膽酸作為治療原發性膽汁性膽管炎的第一線藥物。然而，高昂的治療成本和替代治療方案的存在可能會阻礙市場成長。針對特定適應症的熊去氧膽酸製劑的市場開拓以及提高生物有效性的新技術的出現為市場參與者提供了高成長機會。嚴格的藥品核准法規可能會阻礙市場成長。
本研究的主要特點
該報告對熊去氧膽酸的全球市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球熊去氧膽酸市場的主要企業。
本研究涵蓋的主要企業包括 Dr. Falk Pharma、Daewoong Pharmaceutical、Teva Pharmaceutical、Mitsubishi Tanabe Pharma 和 Lannett Company。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球熊去氧膽酸市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球熊去氧膽酸市場時使用的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球熊去氧膽酸市場－冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球熊去氧膽酸市場，按劑型，2019-2031，（百萬美元）
- 固態劑型
- 液體劑型
第 6 章：2019-2031 年全球熊去氧膽酸市場（以萃取方法）（百萬美元）
- 合成
- 生物
第7章熊去氧膽酸全球市場，依應用分類，2019-2031，（百萬美元）
- 胃腸道疾病
- 肝臟疾病
- 囊腫纖維化
- 其他
第8章全球熊去氧膽酸市場，依通路，2019-2031年，（百萬美元）
- 醫院藥房
- 零售藥房
- 網路藥房
第9章熊去氧膽酸全球市場，按地區，2019-2031，（百萬美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章競爭格局
- 公司簡介
- Dipharma Francis Srl
- ERREGIERRE SpA
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan NV
- Bruschettini SpA
- Impax Laboratories, Inc.
- Shanghai Pharma
第11章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
Global ursodeoxycholic acid market is estimated to be valued at USD 590.1 Mn in 2024 and is expected to reach USD 1,165.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 590.1 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 10.20% | 2031 Value Projection: | US$ 1,165.2 Mn |
Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market growth is driven by rising prevalence of liver diseases and increasing awareness about benefits of ursodeoxycholic acid in their treatment. The market players are investing heavily in R&D to develop new formulations and delivery forms of ursodeoxycholic acid to expand consumer base.
Market Dynamics:
Global ursodeoxycholic acid market growth is driven by rising geriatric population prone to developing liver disorders, increasing healthcare expenditure in developing nations, and growing adoption of ursodeoxycholic acid as first line therapy for PBC. However, high treatment costs and availability of alternative treatment options can hamper the market growth. Development of ursodeoxycholic acid formulations targeted towards specific indications and emergence of novel technologies for enhancing its bioavailability present high growth opportunities for market players. Stringent regulations for drug approvals can hamper the market growth.
Key features of the study:
This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, and Lannett Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market
Detailed Segmentation-
- Dosage Form Insights (Revenue, USD Mn, 2019 - 2031)
- Solid Dosage Form
- Liquid Dosage Form
- Mode of Extraction Insights (Revenue, USD Mn, 2019 - 2031)
- Synthetic
- Biological
- Application Insights (Revenue, USD Mn, 2019 - 2031)
- Gastrointestinal Disorders
- Liver Disorders
- Cystic Fibrosis
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals and Clinics
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Dipharma Francis Srl
- ERREGIERRE S.p.A.
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Mode of Extraction
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Ursodeoxycholic Acid Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Solid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Liquid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Biological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Ursodeoxycholic Acid Market, By Application, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Gastrointestinal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Liver Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2019 - 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Ursodeoxycholic Acid Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Dipharma Francis Srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ERREGIERRE S.p.A.
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
- Dipharma Francis Srl
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
